-
Bright Minds Biosciences (NASDAQ:DRUG) Earns Overweight Rating from Analysts at Piper Sandler
来源: Buzz FX / 23 1月 2025 07:56:18 America/New_York
Bright Minds Biosciences (NASDAQ:DRUG) Earns Overweight Rating from Analysts at Piper Sandler Written by MarketBeat January 23, 2025 Share Link copied to clipboard. Piper Sandler started coverage on shares of Bright Minds Biosciences ( NASD
Read more...